Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiying Qiu

Showing results (151-160 of 194) with videos related to

Pageof 20
Sort By:
Leukemia & Lymphoma|March 25, 2023
RUNX1 together with DAT mutations predicted poor outcome in acute myeloid leukemiaJinyan Xiao, Jundan Xie, Biqi Zhou, et al.
Annals of Hematology|May 22, 2014
High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML)Libing Wang, Lei Gao, Sheng Xu, et al.
Iscience|July 31, 2025
A molecular-based risk score for predicting leukemia-free survival in adult AML patients undergoing Allo-HSCTShuang Li, Huixian Wu, Xiaoxia Hu, et al.
Discover Oncology|July 11, 2025
IPSS-M outperforms IPSS-R in prognostic stratification and guides effective interventions for very High-Risk myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantationHuixian Wu, Shuang Li, Jun Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 12, 2019
Excellent Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Single-Center StudyLimin Liu, Shan Liu, Yanming Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 8, 2014
Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemiaLing Ge, Fan Ye, Xinliang Mao, et al.
Transplantation and Cellular Therapy|August 24, 2020
Comparison of 2 Different Rabbit Anti-Thymocyte Globulin (r-ATG) Preparations: Thymocyte r-ATG versus T Lymphoblast Cell Line r-ATG in Allogeneic Hematopoietic Stem Cell Transplantation for Acquired Severe Aplastic Anemia: Propensity Score-Matched AnalysisLimin Liu, Guofa Xu, Yanming Zhang, et al.
Frontiers in Immunology|November 13, 2023
Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective studyXingying Li, Jun Yang, Yu Cai, et al.
British Journal of Cancer|March 2, 2026
Lymphocyte subset reconstitution and clinical outcomes following haploidentical hematopoietic stem cell transplantationPeiyao Jiang, Xiao Zhou, Yu Cai, et al.
Leukemia Research|May 29, 2025
Parous female donor is not inferior to the young male donor under the low-dose ATG/PTCy combination-based regimen for GVHD prophylaxis in haploidentical peripheral blood stem cell transplantationXingying Li, Yu Cai, Jun Yang, et al.
Pageof 20

Showing results (151-160 of 194) with videos related to

Sort By:
Pageof 20
Leukemia & Lymphoma|March 25, 2023
RUNX1 together with DAT mutations predicted poor outcome in acute myeloid leukemiaJinyan Xiao, Jundan Xie, Biqi Zhou, et al.
Annals of Hematology|May 22, 2014
High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML)Libing Wang, Lei Gao, Sheng Xu, et al.
Iscience|July 31, 2025
A molecular-based risk score for predicting leukemia-free survival in adult AML patients undergoing Allo-HSCTShuang Li, Huixian Wu, Xiaoxia Hu, et al.
Discover Oncology|July 11, 2025
IPSS-M outperforms IPSS-R in prognostic stratification and guides effective interventions for very High-Risk myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantationHuixian Wu, Shuang Li, Jun Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 12, 2019
Excellent Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Single-Center StudyLimin Liu, Shan Liu, Yanming Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 8, 2014
Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemiaLing Ge, Fan Ye, Xinliang Mao, et al.
Transplantation and Cellular Therapy|August 24, 2020
Comparison of 2 Different Rabbit Anti-Thymocyte Globulin (r-ATG) Preparations: Thymocyte r-ATG versus T Lymphoblast Cell Line r-ATG in Allogeneic Hematopoietic Stem Cell Transplantation for Acquired Severe Aplastic Anemia: Propensity Score-Matched AnalysisLimin Liu, Guofa Xu, Yanming Zhang, et al.
Frontiers in Immunology|November 13, 2023
Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective studyXingying Li, Jun Yang, Yu Cai, et al.
British Journal of Cancer|March 2, 2026
Lymphocyte subset reconstitution and clinical outcomes following haploidentical hematopoietic stem cell transplantationPeiyao Jiang, Xiao Zhou, Yu Cai, et al.
Leukemia Research|May 29, 2025
Parous female donor is not inferior to the young male donor under the low-dose ATG/PTCy combination-based regimen for GVHD prophylaxis in haploidentical peripheral blood stem cell transplantationXingying Li, Yu Cai, Jun Yang, et al.
Pageof 20